Clinical Trial Update: Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines [Phase 4]

View source ↗

Summary

The document reports a Phase 4 clinical trial evaluating the immunogenicity and safety of both inactivated and live attenuated hepatitis A vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Havrix (hepatitis A vaccine)
• Live-attenuated hepatitis A vaccine (Hepatitis A vaccine, live-attenuated)
• Vaqta (inactivated hepatitis A vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED